Residency · Roanoke, VA
Sponsored by HCA Healthcare LewisGale Medical Center
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
The New England journal of medicine · 2022 · 255 citations · Mezgebe Berhe
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
The New England journal of medicine · 2022 · 280 citations · Mezgebe Berhe
Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial.
The lancet. HIV · 2023 · 98 citations · Mezgebe Berhe
Transition to telemedicine and its impact on missed appointments in community-based clinics.
Annals of medicine · 2022 · 62 citations · Winston Liaw
Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1 : A Phase 2 Randomized Study.
Annals of internal medicine · 2026 · 9 citations · Mezgebe Berhe
Maternal health outcomes associated with ambient air pollution: An umbrella review of systematic reviews and meta-analyses.
The Science of the total environment · 2024 · 24 citations · Winston Liaw
Competencies for the Use of Artificial Intelligence in Primary Care.
Annals of family medicine · 2022 · 44 citations · Winston Liaw
Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV.
AIDS (London, England) · 2021 · 57 citations · Mezgebe Berhe